Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

Abbott-St. Jude $25 billion deal close to clearance

November 16, 2016 Research and Development, Sales and Marketing Abbott, St. Jude, acquisition

EU antitrust regulators are due to reach a decision on the deal on 23 November that would see Abbott Laboratories …
News
janssen_latest_logo_on_sign_closer

Janssen’s Crohn’s treatment licensed for UK use

November 16, 2016 Research and Development, Sales and Marketing Chrohn's disease, J&J, JJ, Janssen, Johnson & Johnson, Stelara

Janssen, a subsidiary of Johnson & Johnson, has announced that its treatment Stelara (ustekinumab) is now licensed by the European …
News
celgene_1_02

NICE rejects Celegene’s Revlimid as second-line treatment

November 16, 2016 Research and Development, Sales and Marketing Celegene, Revlimid

NICE has decided Celegene’s multiple myeloma growth engine Revlimid (lenalidomide) will not be offered to patients as a second line …
News
nordic-nanovector-big

New CMO and Executive Management Team member for Nordic Nanovector

November 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Nordic Nanovector has recruited a new chief medical officer (CMO) and Executive Management Team member with the appointment of Dr …
Appointment
celgene_1_02

Celgene’s Otezla hits primary endpoint in psoriatic arthritis study

November 15, 2016 Manufacturing and Production, Research and Development Celgene, otezla, psoriatic arthritis

Celgene has unveiled new data on its selective inhibitor of phosphodiesterase 4 (PDE4) Otezla (apremilast) which shows that the treatment …
News
abbvie_0

AbbVie investigational hep C drug boasts 97.5% response rate

November 15, 2016 Manufacturing and Production, Medical Communications, Research and Development AbbVie, hepatitis C, pan-genotypic

AbbVie released details on their latest trials for their investigational, pan-genotypic regimen of glecaprevir (ABT-493)/pibrentasvir (ABT-530). In an eight week …
News

Novartis reveals positive three-year efficacy data for psoriatic arthritis drug

November 15, 2016 Manufacturing and Production, Research and Development Cosentyx, Novartis, psoriatic arthritis

Novartis has claimed that its Cosentyx (secukinumab) treatment is now the first approved fully human interleukin-17A (IL-17A) inhibitor to demonstrate …
News
adriane_brown

Allergan appoints Adriane M. Brown to board of directors

November 14, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan

Allergan announced that Adriana M. Brown will join its board of directors on February 2017. Adriana Brown is currently the …
Appointment

Free Pharmacovigilance Webinar: Available to view now!

November 14, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, pharmacovigilance, primevigilance

Pharmafocus, alongside PrimeVigilance, hosted a webinar on 10 November and is now available to view for free.Throughout the webinar, PrimeVigilance …
News
richard_cm_jones

Mereo BioPharma appoint Richard Jones as CFO

November 14, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mereo BioPharma

Mereo BioPharma, a UK-based biopharmaceutical company, has announced that Richard CM Jones has been appointed chief financial officer of the …
Appointment

Experimental Novartis leukaemia and mastocytosis drug gets FDA Priority Review

November 14, 2016 Research and Development, Sales and Marketing FDA, Novartis, acute myeloid leukaemia

The US FDA has granted Priority Review status to Novartis’ experimental drug PKC412 (midostaurin) as a treatment for advanced systemic …
News
top_ten_1

Top Ten articles in the Pharma Industry this week

November 11, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing November, news, pharmaceutical, top 10, top ten, top ten stories

This week has seen pharmaceutical companies defending their patent protections and host of new collaboration spring up between companies. Read …
News
ex-roche_guy

Former Roche CEO joins Arix Bioscience as senior independent director

November 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Arix Bioscience, a Britain-based healthcare and life science company, appointed Franz Humer as a senior independent director on 31 October. …
Appointment
nhs_trees

Court of Appeal rules that the NHS can legally fund HIV-prevention drug PrEP

November 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Court of Appeals, Gilead, NHS England, Truvada, high court

A High Court ruling that NHS England was legally responsible for preventing the spread of HIV has been upheld when …
News
shutterstock_157775444

Social media and mobile apps: Bringing people and clinical trials together

November 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

In part one, we looked at the difficulty in recruiting and retaining patients for clinical trials, and how increased communication …
Feature
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026